146 related articles for article (PubMed ID: 20622910)
1. Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation.
Gatz SA; Benninghoff U; Schütz C; Schulz A; Hönig M; Pannicke U; Holzmann KH; Schwarz K; Friedrich W
Bone Marrow Transplant; 2011 Apr; 46(4):552-6. PubMed ID: 20622910
[TBL] [Abstract][Full Text] [Related]
2. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
[TBL] [Abstract][Full Text] [Related]
3. Gross generalized molluscum contagiosum in a patient with autosomal recessive hyper-IgE syndrome, which resolved spontaneously after haematopoietic stem-cell transplantation.
Siah TW; Gennery A; Leech S; Taylor A
Clin Exp Dermatol; 2013 Mar; 38(2):196-7. PubMed ID: 23020750
[No Abstract] [Full Text] [Related]
4. Hyper-IgE syndromes.
Grimbacher B; Holland SM; Puck JM
Immunol Rev; 2005 Feb; 203():244-50. PubMed ID: 15661034
[TBL] [Abstract][Full Text] [Related]
5. Molluscum contagiosum and Job's syndrome.
Martins MN; Tullu MS; Mahajan SA
J Postgrad Med; 2001; 47(4):268-9. PubMed ID: 11832646
[No Abstract] [Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.
Goussetis E; Peristeri I; Kitra V; Traeger-Synodinos J; Theodosaki M; Psarra K; Kanariou M; Tzortzatou-Stathopoulou F; Petrakou E; Fylaktou I; Kanavakis E; Graphakos S
J Allergy Clin Immunol; 2010 Aug; 126(2):392-4. PubMed ID: 20584545
[No Abstract] [Full Text] [Related]
8. Aberrant humoral immune reactivity in DOCK8 deficiency with follicular hyperplasia and nodal plasmacytosis.
aan de Kerk DJ; van Leeuwen EM; Jansen MH; van den Berg JM; Alders M; Vermont CL; van Lier RA; Pals ST; Kuijpers TW
Clin Immunol; 2013 Oct; 149(1):25-31. PubMed ID: 23891736
[TBL] [Abstract][Full Text] [Related]
9. Treosulfan-based conditioning in DOCK8 deficiency: complete lympho-hematopoietic reconstitution with minimal toxicity.
Ghosh S; Schuster FR; Fuchs I; Laws HJ; Borkhardt A; Meisel R
Clin Immunol; 2012 Dec; 145(3):259-61. PubMed ID: 23128504
[No Abstract] [Full Text] [Related]
10. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.
Minegishi Y; Karasuyama H
Int Immunol; 2009 Feb; 21(2):105-12. PubMed ID: 19088064
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome.
Kilic SS; Kilicbay F
Pediatrics; 2006 Jun; 117(6):e1253-1255. PubMed ID: 16651279
[TBL] [Abstract][Full Text] [Related]
12. Unusual coexistence of molluscum contagiosum and verruca plana in a hyper-IgE syndrome.
Lei XB; Geng SM; Zeng WH; Tan SS; Wang JM; Xiao SX
Int J Dermatol; 2006 Oct; 45(10):1199-201. PubMed ID: 17040440
[No Abstract] [Full Text] [Related]
13. A young man with hyperimmunoglobulin-E syndrome and IgA and IgG deficiencies.
Fuller K; Pearce A; Raftos J
Clin Exp Dermatol; 2007 Jul; 32(4):391-4. PubMed ID: 17362234
[TBL] [Abstract][Full Text] [Related]
14. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity.
Renner ED; Puck JM; Holland SM; Schmitt M; Weiss M; Frosch M; Bergmann M; Davis J; Belohradsky BH; Grimbacher B
J Pediatr; 2004 Jan; 144(1):93-9. PubMed ID: 14722525
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors.
Kono A; Wakamatsu M; Umezawa Y; Muramatsu H; Fujiwara H; Tomomasa D; Inoue K; Hattori K; Mitsui T; Takada H; Minegishi Y; Takahashi Y; Yamamoto M; Mori T; Kanegane H
Int J Hematol; 2023 Oct; 118(4):519-525. PubMed ID: 37131080
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation does not correct the hyper IgE syndrome.
Gennery AR; Flood TJ; Abinun M; Cant AJ
Bone Marrow Transplant; 2000 Jun; 25(12):1303-5. PubMed ID: 10871737
[TBL] [Abstract][Full Text] [Related]
17. Moderate-dose intravenous immunoglobulin treatment of Job's syndrome. Case report.
Bilora F; Petrobelli F; Boccioletti V; Pomerri F
Minerva Med; 2000; 91(5-6):113-6. PubMed ID: 11084845
[TBL] [Abstract][Full Text] [Related]
18. [Necrotising fasciitis in hyper-IgE syndrome].
Erdos M; Nagy L; Szentkereszty Z; Sáfrány G; Maródi L
Orv Hetil; 2004 Jun; 145(26):1367-72. PubMed ID: 15384746
[TBL] [Abstract][Full Text] [Related]
19. The clinical and laboratory survey of Iranian patients with hyper-IgE syndrome.
Moin M; Farhoudi A; Movahedi M; Rezaei N; Pourpak Z; Yeganeh M; Gharagozlou M; Mirsaeid Ghazi B; Arshi S; Mansouri D; Sherkat R; Kashef S; Mahmoudi M; Nabavi M; Aghamohammadi A
Scand J Infect Dis; 2006; 38(10):898-903. PubMed ID: 17008235
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis.
Olaiwan A; Chandesris MO; Fraitag S; Lortholary O; Hermine O; Fischer A; de Prost Y; Picard C; Bodemer C
J Am Acad Dermatol; 2011 Dec; 65(6):1167-72. PubMed ID: 21703716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
